Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
SEATTLE --(BUSINESS WIRE)--Oct. 13, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
SEATTLE --(BUSINESS WIRE)--Oct. 7, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public offering of 5,000,000 shares of its common stock at a price to the
View HTML
Toggle Summary NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE --(BUSINESS WIRE)--Oct. 6, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common
View HTML
Toggle Summary NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
- Third Quarter Product and Service Revenue of $30.1 Million vs. Guidance Range of $25 to $28 Million - - More than 25 New GeoMx DSP Orders Received in the Third Quarter - SEATTLE --(BUSINESS WIRE)--Oct. 6, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools
View HTML
Toggle Summary NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
SEATTLE --(BUSINESS WIRE)--Oct. 5, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release third quarter 2020 operating results after the close of the market on Monday,
View HTML
Toggle Summary NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
Whole Transcriptome Atlas Service Based in NanoString’s Seattle Labs Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE --(BUSINESS WIRE)--Sep. 14, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
View HTML
Toggle Summary NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Sep. 9, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Morgan Stanley Global Healthcare Conference .
View HTML
Toggle Summary NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
Global Network to Establish Standards for Spatial Research Key COVID-19 Findings to be Highlighted at an Upcoming Spatial Biology Conference SEATTLE --(BUSINESS WIRE)--Sep. 9, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and
View HTML
Toggle Summary NanoString to Present at the 2020 Baird Global Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Sep. 3, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Baird Global Healthcare Conference .
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Second Quarter of 2020
SEATTLE --(BUSINESS WIRE)--Aug. 10, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter of 2020. This press release features multimedia.
View HTML